SCHEMBL7351830

SCHEMBL7351830

CC(=O)CC(C(C)=O)(c1ccccc1)c1c(O)c2ccccc2oc1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.50
▸ CYP2C9 P11712 3/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ ALB P02768 2/20 0.50
▸ VKORC1 Q9BQB6 2/20 0.50
▸ PCSK7 Q16549 2/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ CA12 O43570 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ NQO1 P15559 3/20 0.45
▸ ABCB11 O95342 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3778823 0.84 ALDH1A1 (0.51) ALDH1A1CYP2C9KDM4EALBVKORC1
SCHEMBL15514111 0.84 ALDH1A1 (0.51) ALDH1A1CYP2C9KDM4EALBVKORC1
SCHEMBL1649890 0.82 NQO1 (0.50) ALDH1A1CYP2C9KDM4EALBVKORC1
SCHEMBL5103338 0.81 NQO1 (0.52) ALDH1A1CYP2C9KDM4EALBVKORC1
SCHEMBL3048772 0.79 ALDH1A1 (0.46) ALDH1A1CYP2C9KDM4EALBVKORC1
SCHEMBL6890789 0.79 CYP2C9 (0.52) ALDH1A1CYP2C9KDM4EALBVKORC1
SCHEMBL2358729 0.78 LMNA (0.48) ALDH1A1CYP2C9KDM4EALBVKORC1
SCHEMBL7354341 0.76 KDM4E (0.55) ALDH1A1CYP2C9KDM4EALBVKORC1
SCHEMBL9286035 0.76 NQO1 (0.53) ALDH1A1CYP2C9KDM4EVKORC1PCSK7
SCHEMBL12091846 0.73 CA12 (0.49) ALDH1A1CYP2C9KDM4EALBVKORC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0682663-B1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS UPJOHN CO (US) 2001-04-18 — — EP disclosed
US-6169181-B1 HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITORS PHARMACIA & UPJOHN COMPANY 2001-01-02 — — US disclosed
US-5852195-A Pyranone compounds useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1998-12-22 — — US disclosed
US-5686486-A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1997-11-11 — — US disclosed
EP-0758327-A1 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1997-02-19 — — EP disclosed
EP-0682663-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-22 — — EP disclosed
WO-1995030670-A2 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-16 — — WO disclosed
WO-1994018188-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS THE UPJOHN COMPANY (US) 1994-08-18 — — WO disclosed
Send feedback